High-Glucose environment enhanced oxidative stress and increased interleukin-8 secretion from keratinocytes

Diabetes

Volumn 62, Issue 7, 2013, Pages 2530-2538

  Lan, Cheng Che E ^a,b,c   Wu, Ching Shuang ^c   Huang, Shu Mei ^a,b,d   Wu, I Hui ^a,b   Chen, Gwo Shing ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CXCL1 CHEMOKINE; DAPSONE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; FLOW CYTOMETRY; GENE SILENCING; KERATINOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SKIN; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; WESTERN BLOTTING; WOUND HEALING IMPAIRMENT; ANIMAL; CELL CULTURE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HUMAN; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HUMANS; INTERLEUKIN-8; KERATINOCYTES; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SKIN; WOUND HEALING;

EID: 84883692777     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1714     Document Type: Article

References (35)

1. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997;29:5-17
2. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341: 738-746
3. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005;366:1736-1743
4. Goodson WH 3rd, Hung TK. Studies of wound healing in experimental diabetes mellitus. J Surg Res 1977;22:221-227
5. Wertheimer E, Spravchikov N, Trebicz M, et al. The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. Endocrinology 2001;142:1234-1241
6. Danaei G, Finucane MM, Lu Y, et al.; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2$7 million participants. Lancet 2011;378:31-40
7. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005;15:599-607
8. Simpson DM, Ross R. The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J Clin Invest 1972;51:2009-2023
9. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007;127:514-525
10. Moore K. Cell biology of chronic wounds: the role of inflammation. J Wound Care 1999;8:345-348
11. Pierce GF. Inflammation in nonhealing diabetic wounds: the space-time continuum does matter. Am J Pathol 2001;159:399-403
12. Hamed S, Ullmann Y, Egozi D, et al. Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice. J Invest Dermatol 2011;131:1365-1374
13. Schürmann C, Linke A, Engelmann-Pilger K, et al. The dipeptidyl peptidase- 4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice. J Pharmacol Exp Ther 2012;342:71-80
14. Dovi JV, He LK, DiPietro LA. Accelerated wound closure in neutrophildepleted mice. J Leukoc Biol 2003;73:448-455
15. Rennekampff HO, Hansbrough JF, Kiessig V, Doré C, Sticherling M, Schröder JM. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 2000;93:41-54
16. Roupé KM, Nybo M, Sjöbring U, Alberius P, Schmidtchen A, Sørensen OE. Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol 2010;130:1167-1177
17. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/ interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-1049
18. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988;167:1547-1559
19. Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun 2009;77:456-463
20. Lan CC, Liu IH, Fang AH, Wen CH, Wu CS. Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes. Br J Dermatol 2008;159:1103-1115
21. Lan CC, Wu CS, Huang SM, et al. High-glucose environment inhibits p38MAPK signaling and reduces human β-defensin-3 expression [corrected] in keratinocytes. Mol Med 2011;17:771-779
22. Huang SM, McCance DJ. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J Virol 2002;76:8710-8721
23. Frankart A, Coquette A, Schroeder KR, Poumay Y. Studies of cell signaling in a reconstructed human epidermis exposed to sensitizers: IL-8 synthesis and release depend on EGFR activation. Arch Dermatol Res 2012;304:289-303
24. Zhang Y, Wang L, Zhang M, Jin M, Bai C, Wang X. Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGFEGFR- PI3K-Akt-Erk pathway. J Cell Physiol 2012;227:35-43
25. Liu J, Zhao S, Tang J, et al. Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB. FEBS J 2009;276:4598-4606
26. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820
27. Hwang YS, Jeong M, Park JS, et al. Interleukin-1beta stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. Oncogene 2004;23:6603-6611
28. Nakai K, Yoneda K, Igarashi J, Moriue T, Kosaka H, Kubota Y. Angiotensin II enhances EGF receptor expression levels via ROS formation in HaCaT cells. J Dermatol Sci 2008;51:181-189
29. von Montfort C, Fernau NS, Beier JI, Sies H, Klotz LO. Extracellular generation of hydrogen peroxide is responsible for activation of EGF receptor by ultraviolet A radiation. Free Radic Biol Med 2006;41:1478-1487
30. Jin GH, Liu Y, Jin SZ, Liu XD, Liu SZ. UVB induced oxidative stress in human keratinocytes and protective effect of antioxidant agents. Radiat Environ Biophys 2007;46:61-68
31. Park NY, Lim Y. Short term supplementation of dietary antioxidants selectively regulates the inflammatory responses during early cutaneous wound healing in diabetic mice. Nutr Metab (Lond) 2011;8:80
32. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309-1312
33. Nawroth P, Handley D, Matsueda G, et al. Tumor necrosis factor/cachectininduced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med 1988;168:637-647
34. Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL. Neutrophilderived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy 2005;4:273-279
35. Wozel G, Lehmann B. Dapsone inhibits the generation of 5-lipoxygenase products in human polymorphonuclear leukocytes. Skin Pharmacol 1995; 8:196-202